PCM
VANI icon

Prelude Capital Management’s Vivani Medical VANI Stock Holding History

Prelude Capital Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-21
Closed -$7K – 1812
2015
Q2 		$7K Buy
+21
New +$6.73K ﹤0.01% 1597

Other funds holding VANI

TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prelude Capital Management's VANI Position: Q4 2023 in Review

Prelude Capital Management sold out of Vivani Medical (VANI) in Q4 2023, closing a stake of 10,996 shares — an estimated $11.2K sold.

Prelude Capital Management first reported a position in VANI in Q3 2022 and held it in 5 quarters. The position peaked at $25K in Q3 2022. 31 funds tracked by Wall St. Rank hold VANI as of Q4 2023.

  • Prelude Capital Management reported no remaining Vivani Medical position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 10,996 Vivani Medical shares in Q4 2023, an estimated $11.2K.
  • Prelude Capital Management first reported a position in Vivani Medical in Q3 2022 and held it in 5 quarters.
  • Prelude Capital Management's Vivani Medical position peaked at $25K in Q3 2022.
  • 31 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.